154 related articles for article (PubMed ID: 25500828)
1. Toward radioguided surgery with β- decays: uptake of a somatostatin analogue, DOTATOC, in meningioma and high-grade glioma.
Collamati F; Pepe A; Bellini F; Bocci V; Chiodi G; Cremonesi M; De Lucia E; Ferrari ME; Frallicciardi PM; Grana CM; Marafini M; Mattei I; Morganti S; Patera V; Piersanti L; Recchia L; Russomando A; Sarti A; Sciubba A; Senzacqua M; Solfaroli Camillocci E; Voena C; Pinci D; Faccini R
J Nucl Med; 2015 Jan; 56(1):3-8. PubMed ID: 25500828
[TBL] [Abstract][Full Text] [Related]
2. Time Evolution of DOTATOC Uptake in Neuroendocrine Tumors in View of a Possible Application of Radioguided Surgery with β- Decay.
Collamati F; Bellini F; Bocci V; De Lucia E; Ferri V; Fioroni F; Grassi E; Iori M; Marafini M; Morganti S; Paramatti R; Patera V; Recchia L; Russomando A; Sarti A; Sciubba A; Senzacqua M; Solfaroli Camillocci E; Versari A; Voena C; Faccini R
J Nucl Med; 2015 Oct; 56(10):1501-6. PubMed ID: 26338895
[TBL] [Abstract][Full Text] [Related]
3. Radioguided surgery with β
Collamati F; Maccora D; Alfieri S; Bocci V; Cartoni A; Collarino A; Simoni M; Fischetti M; Fratoddi I; Giordano A; Mancini-Terracciano C; Mirabelli R; Morganti S; Quero G; Rotili D; Scotognella T; Solfaroli Camillocci E; Traini G; Venditti I; Faccini R
Sci Rep; 2020 Mar; 10(1):4015. PubMed ID: 32132632
[TBL] [Abstract][Full Text] [Related]
4. First ex vivo validation of a radioguided surgery technique with β-radiation.
Solfaroli Camillocci E; Schiariti M; Bocci V; Carollo A; Chiodi G; Colandrea M; Collamati F; Cremonesi M; Donnarumma R; Ferrari ME; Ferroli P; Ghielmetti F; Grana CM; Mancini Terracciano C; Marafini M; Morganti S; Patanè M; Pedroli G; Pollo B; Recchia L; Russomando A; Toppi M; Traini G; Faccini R
Phys Med; 2016 Sep; 32(9):1139-44. PubMed ID: 27601248
[TBL] [Abstract][Full Text] [Related]
5. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
[TBL] [Abstract][Full Text] [Related]
6. First
Bertani E; Collamati F; Colandrea M; Faccini R; Fazio N; Ferrari ME; Fischetti M; Fumagalli Romario U; Funicelli L; De Simoni M; Mancini-Terracciano C; Mirabelli R; Morganti S; Papi S; Pisa E; Solfaroli-Camillocci E; Spada F; Cremonesi M; Grana CM
Cancer Biother Radiopharm; 2021 Jun; 36(5):397-406. PubMed ID: 33601932
[No Abstract] [Full Text] [Related]
7. Pearls and Pitfalls in Interpretation of 68Ga-DOTATOC PET Imaging.
Bashir A; Broholm H; Clasen-Linde E; Vestergaard MB; Law I
Clin Nucl Med; 2020 Jun; 45(6):e279-e280. PubMed ID: 32332303
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
[TBL] [Abstract][Full Text] [Related]
9. Radio-Guided Surgery with a New-Generation β-Probe for Radiolabeled Somatostatin Analog, in Patients with Small Intestinal Neuroendocrine Tumors.
Bertani E; Mattana F; Collamati F; Ferrari ME; Bagnardi V; Frassoni S; Pisa E; Mirabelli R; Morganti S; Fazio N; Fumagalli Romario U; Ceci F
Ann Surg Oncol; 2024 Jul; 31(7):4189-4196. PubMed ID: 38652200
[TBL] [Abstract][Full Text] [Related]
10. A novel radioguided surgery technique exploiting β(-) decays.
Camillocci ES; Baroni G; Bellini F; Bocci V; Collamati F; Cremonesi M; De Lucia E; Ferroli P; Fiore S; Grana CM; Marafini M; Mattei I; Morganti S; Paganelli G; Patera V; Piersanti L; Recchia L; Russomando A; Schiariti M; Sarti A; Sciubba A; Voena C; Faccini R
Sci Rep; 2014 Mar; 4():4401. PubMed ID: 24646766
[TBL] [Abstract][Full Text] [Related]
11. The β
Russomando A; Schiariti M; Bocci V; Colandrea M; Collamati F; Cremonesi M; Ferrari ME; Ferroli P; Ghielmetti F; Ghisini R; Grana CM; Mancini Terracciano C; Marafini M; Mirabelli R; Morganti S; Papi S; Patanè M; Pedroli G; Pollo B; Solfaroli Camillocci E; Traini G; Faccini R
Phys Med; 2019 Feb; 58():114-120. PubMed ID: 30824142
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
Afshar-Oromieh A; Wolf MB; Kratochwil C; Giesel FL; Combs SE; Dimitrakopoulou-Strauss A; Gnirs R; Roethke MC; Schlemmer HP; Haberkorn U
Neuro Oncol; 2015 Feb; 17(2):312-9. PubMed ID: 25008094
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.
Kiviniemi A; Gardberg M; Autio A; Li XG; Heuser VD; Liljenbäck H; Käkelä M; Sipilä H; Kurkipuro J; Ylä-Herttuala S; Knuuti J; Minn H; Roivainen A
Acta Oncol; 2014 Aug; 53(8):1125-34. PubMed ID: 24957558
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.
Seystahl K; Stoecklein V; Schüller U; Rushing E; Nicolas G; Schäfer N; Ilhan H; Pangalu A; Weller M; Tonn JC; Sommerauer M; Albert NL
Neuro Oncol; 2016 Nov; 18(11):1538-1547. PubMed ID: 27106404
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.
Marincek N; Radojewski P; Dumont RA; Brunner P; Müller-Brand J; Maecke HR; Briel M; Walter MA
J Nucl Med; 2015 Feb; 56(2):171-6. PubMed ID: 25593116
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas.
Gay E; Vuillez JP; Palombi O; Brard PY; Bessou P; Passagia JG
Neurosurgery; 2005 Jul; 57(1 Suppl):107-13; discussion 107-13. PubMed ID: 15987576
[TBL] [Abstract][Full Text] [Related]
19. Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide.
Förster GJ; Engelbach MJ; Brockmann JJ; Reber HJ; Buchholz HG; Mäcke HR; Rösch FR; Herzog HR; Bartenstein PR
Eur J Nucl Med; 2001 Dec; 28(12):1743-50. PubMed ID: 11734910
[TBL] [Abstract][Full Text] [Related]
20. Radioguided improved resection of a cranial base meningioma.
Dammers R; Hsu SP; Krisht AF
Neurosurgery; 2009 Mar; 64(3 Suppl):ons84-5; discussion ons85. PubMed ID: 19240580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
